As PKCε is involved in drug resistance in some types of cancer and adjuvant chemotherapy is commonly used to treat RCC, we tested whether PKCε is also involved in drug response of RCC cell lines. The gene discussed is PRKCE; the disease is renal cell adenocarcinoma.